Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (2)
Cell Death Discovery (1)
Nature Cell Biology (1)
Communications Biology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Developmental biology
Genetics
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–5 of 5 results

Advanced filters: Author: Stephanie Borlase Clear advanced filters

A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing

Werbowetski-Ogilvie, Taylor and colleagues report a noncanonical role for OTX2 in regulating alternative splicing and controlling a stem cell and pro-tumorigenic splicing program in group 3 medulloblastoma.

Olivier Saulnier
Jamie Zagozewski
Tamra E. Werbowetski-Ogilvie
ResearchOpen Access18 Jul 2024
Nature Cell Biology

Volume: 26, P: 1233-1246
Failure of human rhombic lip differentiation underlies medulloblastoma formation

Derailed differentiation of human-specific progenitors of the developing cerebellar rhombic lip is the cause of group 4 medulloblastoma, the most common childhood brain tumour.

Liam D. Hendrikse
Parthiv Haldipur
Michael D. Taylor
Research21 Sept 2022
Nature

Volume: 609, P: 1021-1028
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

Liam D. Hendrikse
Parthiv Haldipur
Michael D. Taylor
Amendments and Corrections29 Nov 2022
Nature

Volume: 612, P: E12
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression

RNA sequencing of MEK inhibitor (selumetinib)-treated tumors reveals an upregulation of the JAK/STAT3 pathway, with combinatorial therapeutic strategies of JAK/STAT3 inhibitors and selumetinib investigated for the SHH subgroup of medulloblastoma.

Jamie Zagozewski
Stephanie Borlase
Tamra E. Werbowetski-Ogilvie
ResearchOpen Access14 Jul 2022
Communications Biology

Volume: 5, P: 1-17
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression

Stephanie Borlase
Alexandria DeCarlo
Tamra E. Werbowetski-Ogilvie
ResearchOpen Access19 Sept 2023
Cell Death Discovery

Volume: 9, P: 1-13